Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

• Linda Mileshkin,
• Ben Markman,
• Oliver Klein,
• Damien Kee,
• Jonathan Cebon,
• Andreas Behren,
• Matteo Carlino,
• Bo Gao,
• Jessica da Gama Duarte,
• Luke Quigley,
• Louise Jackett,
• Richelle Linklater,
• Andrew Strickland,
• Clare Scott,
• Jodie Palmer

Affiliations

Linda Mileshkin

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Ben Markman

Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia

Oliver Klein

Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Victoria, Australia

Damien Kee

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Jonathan Cebon

Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Victoria, Australia

Andreas Behren

Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia

Matteo Carlino

Blacktown Hospital and the University of Sydney, Sydney, New South Wales, Australia

Bo Gao

Blacktown Hospital and the University of Sydney, Sydney, New South Wales, Australia

Jessica da Gama Duarte

Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia

Luke Quigley

Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia

Louise Jackett

Department of Anatomical Pathology, Austin Health, Melbourne, Victoria, Australia

Richelle Linklater

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Andrew Strickland

Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia

Clare Scott

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Jodie Palmer

Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia